Godrej Agrovet Ltd
Godrej Agrovet Q2 FY26 earnings call: Revenue & Margins
Q2 FY26 earnings call: what management guided on revenue, margins and order book.
The short version
Godrej Agrovet aims for strong, healthy revenue growth in fiscal year 2026 despite challenges like adverse rainfall affecting Crop Protection segment. Godrej Agrovet's net profit growth over the past 8 years has been modest, at around 7% CAGR, with expectations to more than double profits still unmet.
From Godrej Agrovet Ltd's Q2 FY26 earnings-call transcript · updated 16 Oct 2026.
Revenue & Sales Performance
- Godrej Agrovet aims for strong, healthy revenue growth in fiscal year 2026 despite challenges like adverse rainfall affecting Crop Protection segment.
- Animal Feed volume growth is very strong, expected to continue robustly, with stable underlying EBIT per metric ton.
- Oil Palm business is on a growth trajectory, with significant planting done; benefits expected over 4-5 years.
- CDMO business is growing rapidly, from 26% to 54% of revenue recently, with plans to sustain or increase this share and break even on EBITDA by year-end.
- R&D pipeline is full, and new product commercialization is expected to increase in 1-2 years, supporting future sales growth.
- Volume-led growth is a key focus, as pricing is volatile; recent 15% top-line growth primarily volume-driven.
2 more points from Godrej Agrovet Ltd's call on revenue
Pro opens every point from 15K+ earnings calls
Profitability & Margins
See what Godrej Agrovet Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- The company is undertaking a strategy refresh exercise focusing on portfolio choices and growth pillars over the next 70-90 days, which may influence future investments.
- There is a strong push toward value-added portfolios across businesses (animal feed, foods, Astec) signaling potential capital allocation toward innovation and premium products.
- The CDMO (Contract Development and Manufacturing Organization) business is expanding, with significant R&D investments in infrastructure supporting up to 100 simultaneous reactions and capacity utilization near 90%.
- Plans to commercialize more products within 1-2 years indicate ongoing R&D spending and scale-up investments, although currently, no scale-up is underway in the R&D center.
- Oil palm business is on a growth track with high levels of planting this year; benefits expected in 4-5 years imply ongoing capital investments.
2 more points from Godrej Agrovet Ltd's call on capex
Pro opens every point from 15K+ earnings calls
Top-ranked in Food Products
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Godrej Agrovet Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- All CDMO businesses are intact with normal demand indications from clients.
- There has been a typical shift in the CDMO order book timing from Q2 to Q3 and Q4, considered a normal phasing pattern.
- CDMO order books are expected to have similar salience at the year-end as last year.
- New investments are underway to strengthen the CDMO pipeline, including building a strong B2B go-to-market strategy and business development team.
2 more points from Godrej Agrovet Ltd's call on order book
Pro opens every point from 15K+ earnings calls
Godrej Agrovet Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹2.3K Cr, net profit ₹102 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Godrej Agrovet Ltd's management said in earlier quarters
Others in Food Products this season
- HMA Agro Industries Ltd (Q2 FY26)
Half-year revenue increased by 57% YoY, with consolidated EBITDA margin expanding from 1.48% to 6.10%. Key concall takeaways from HMA Agro Industries Ltd's Q2…
- Dodla Dairy Ltd (Q2 FY26)
Value-added product sales (excluding bulk) showing positive momentum with a 22% YoY growth in Q2 FY '26. Key concall takeaways from Dodla Dairy Ltd's Q2 FY26…
- Annapurna Swadisht Ltd (Q2 FY26)
Consolidated total revenue for H1FY26: ₹249.90 crore, up 22.37% YoY (Page 6) . Key concall takeaways from Annapurna Swadisht Ltd's Q2 FY26 earnings call — and…
- Prataap Snacks Ltd (Q2 FY26)
4,298 million, a 2% decline YoY (from Rs. Key concall takeaways from Prataap Snacks Ltd's Q2 FY26 earnings call — and how it ranks against sector peers.
Arthneeti Pro · Annual
Godrej Agrovet Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Godrej Agrovet Ltd Q2 FY26 results?
Godrej Agrovet aims for strong, healthy revenue growth in fiscal year 2026 despite challenges like adverse rainfall affecting Crop Protection segment. Godrej Agrovet's net profit growth over the past 8 years has been modest, at around 7% CAGR, with expectations to more than double profits still unmet.
What is Godrej Agrovet Ltd share price analysis?
Godrej Agrovet Ltd currently shows a neutral. The stock trades at a P/E of 25.9 with a market cap of ₹12,175 Cr. Investors should review the full earnings analysis for detailed insights.
Is Godrej Agrovet Ltd planning capital expenditure?
The company is undertaking a strategy refresh exercise focusing on portfolio choices and growth pillars over the next 70-90 days, which may influence future investments.
Keep Godrej Agrovet Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.